Dental Reviewed
Industry News

Curve Dental Commits $200 Million To R&D As Cloud Platform Nears $100M ARR

Curve Dental announced a $200 million R&D investment on August 20, 2026. The funding targets its Curve Hero cloud platform and its ecosystem of native tools. Chairman and CEO...

Written by Maren Solvik

Read time: 4 min read
Curve Dental Commits $200 Million To R&D As Cloud Platform Nears $100M ARR

Curve Dental announced a $200 million R&D investment on August 20, 2026. The funding targets its Curve Hero cloud platform and its ecosystem of native tools. Chairman and CEO Dave Cormack backed the news with a blunt warning for competitors. The company itself is approaching $100 million in annual recurring revenue.

TL;DR

  • Curve Dental commits $200 million in new R&D funding for its Curve Hero platform.

  • The company nears $100 million in annual recurring revenue through organic growth.

  • CEO Dave Cormack predicts over 40 percent of practice management vendors will disappear within four years.

  • Curve holds close to 20 percent of the cloud dental practice management market.

What Curve Dental Announced

Curve Dental confirmed the funding commitment through its own newsroom. The company published the news on August 20, 2026. The announcement adds to $100 million already spent on R&D over the past eight years. Combined, the two figures put Curve's product investment near $300 million since current leadership took over.

The funding goes toward Curve Hero, the company's flagship cloud platform. It also covers a wider ecosystem of native capabilities built around that platform. Curve Dental serves single-location practices, small groups, and DSOs. It operates across the United States and Canada.

Curve's Revenue And Market Position

Curve Dental is nearing $100 million in annual recurring revenue. Almost all of that growth has come from organic customer adoption rather than acquisitions. The company holds close to 20 percent of the cloud dental practice management market.

Dave Cormack serves as Chairman and Chief Executive Officer. He has spent 40 years working in high-growth software companies. Cormack previously led Brightree, a homecare software platform, from startup to market leader. He and the current leadership team acquired Curve Dental nine years ago.

“Nine years ago, today's leadership team at Curve, having previously grown Brightree from a startup to the most successful cloud software platform in the homecare market, fell in love with the opportunity to deliver the most compelling solution for the dental industry when we saw that close to 100% of the market was relying on 20- to 30-year-old client-server solutions. No other opportunity in healthcare came close,” Dave Cormack noted.

What The Investment Will Fund

The $200 million adds to spending Curve has already disclosed. In 2025, the company said it was committing $20 million a year to AI. That funding built out Curve FLO AI, a suite already live inside the platform.

Curve lists several native capabilities already built on that platform.

  • Patient engagement tools for scheduling and communication, branded Curve GRO.

  • Eligibility+, an AI-powered insurance verification tool.

  • Curve Pay, integrated payment processing with next-day deposits.

  • Curve Care+, a voice-driven suite for notes, charting, and perio documentation.

  • Ask CurveAI, an in-platform assistant for software and workflow questions.

  • Revenue cycle management, sometimes shortened to RCM.

  • Membership plan administration for patients without insurance.

  • Orthodontics-specific workflow tools.

  • Business intelligence reporting and analytics.

Suzanne Henderson, Curve Dental's Chief Technology Officer, has spoken about the thinking behind tools like Eligibility+. “We're not just digitizing verification, we're rethinking it,” Henderson said.

Curve reports that practices using its AI Suite save staff time. The company also reports fewer missed steps on treatment plans. Curve cites up to 280 minutes saved per day for some practices. It also cites a 40 percent drop in administrative workload. A 20 percent lift in treatment acceptance is another figure Curve reports. Results vary by practice size and adoption.

Cormack said multi-practice software rarely scales down well for solo and small group practices. He said Curve built its platform natively for practices of every size. That approach differs from adapting a large-scale system after the fact. Curve also offers API access so practices can connect approved third-party vendors where needed.

Cormack On Market Consolidation

Cormack expects large changes across the dental software market. He set that timeline at the next several years. He pointed to how many practices still run on older systems.

Roughly 160,000 dental practices operate across North America. About 85 percent of them still run legacy client-server software, according to Cormack's estimate. He expects that gap to close quickly as more practices move to the cloud.

Cormack predicted that vendor numbers will shrink as that shift plays out. He said more than 40 percent of practice management vendors will not exist. His timeline for that was 36 to 48 months. He linked part of that prediction to companies spending on acquisitions instead of R&D and support. “A dental software death spiral is upon us,” Cormack said.

Cormack also raised concerns about platforms built through acquisition rather than native development. He said acquired product collections often leave practices with fragmented data. Separate interfaces and inconsistent workflows across tools add complexity for staff. He said Curve's fully native build avoids that fragmentation.

What This Means For Dental Practices

Software vendor stability is a practical concern. Any practice evaluating a switch should weigh it. A vendor's R&D spending and profitability offer some signal about long-term support.

Practices comparing platforms typically look at how patient records, billing, and scheduling connect. A single platform that keeps clinical and financial data together simplifies staff training. It also reduces the manual work needed to keep separate systems in sync.

Consolidation in the vendor market also affects practices planning a sale or acquisition. Buyers often inherit the seller's technology stack along with the patient base. Software continuity is one more factor to weigh during that kind of transition.

Practices already using AI tools for insurance or charting may benefit first. New features under this funding could reach them before other users. Practices still on legacy systems have more reason to plan ahead. A migration timeline set in advance beats one forced by a vendor's financial trouble.

What To Expect Next

Curve has released new AI features every few months over the past two years. Ask CurveAI launched in February 2025. Eligibility+ followed in August 2025, alongside the wider Curve FLO AI suite. Curve Care+ launched in July 2026 as a voice-driven tool for clinical documentation.

Jana Macon, Curve Dental's President, spoke about that release pace when Ask CurveAI launched. "Curve has always prioritized innovation that simplifies practice management," Macon said.

Given that pace, further additions to the Curve+ AI Suite are likely over the next year. Cormack's comments point toward continued spending on eligibility checks, payments, and clinical documentation. They point less toward a shift into new product categories. The company has not given a public roadmap for the $200 million figure. No release date has been tied to it either.

Practices already on Curve can expect ongoing updates rolled into their existing subscription. Practices evaluating a switch should ask any vendor for specifics. That includes what a stated investment figure funds and on what timeline.

Bottom Line

Curve Dental has added $200 million to its R&D budget for Curve Hero. The company is nearing $100 million in annual recurring revenue. That growth came mostly through organic customer adoption. Chairman and CEO Dave Cormack expects the market to consolidate over the next few years. He advises practices to weigh a vendor's R&D spending and profitability before switching systems. Practices considering a move should treat platform architecture as seriously as the feature list.

Frequently Asked Questions

How much is Curve Dental investing in R&D?

Curve Dental announced a further $200 million in R&D funding on August 20, 2026, on top of $100 million already spent over the past eight years.

What is Curve Hero?

Curve Hero is Curve Dental's flagship cloud-based, single sign-on practice management platform.

How much market share does Curve Dental hold?

Curve Dental holds close to 20 percent of the cloud dental practice management market, according to the company.

Continue Reading